Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis

American Journal of Therapeutics

Volumn 13, Issue 2, 2006, Pages 171-174

  Gandelman, Glenn ^a   Aronow, Wilbert S ^a   Weiss, Melvin B ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cholestasis; Coronary artery disease; Dyslipidemia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN X; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL; URSODEOXYCHOLIC ACID; LIPID;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; INTRAHEPATIC CHOLESTASIS; LIVER TRANSPLANTATION; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHOLESTASIS; CORONARY ARTERY ATHEROSCLEROSIS; LIVER FUNCTION TEST; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; SCLEROSING CHOLANGITIS;

CHOLANGITIS, SCLEROSING; CHOLESTASIS; CORONARY ARTERIOSCLEROSIS; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 33646571155     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200603000-00014     Document Type: Article

References (16)

1. Jorgensen RA, Lindor KD, Sartin JS, et al. Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. J Clin Gastroenterol. 1995;20:215-219.
2. Jahn CE, Schaefer EJ, Taam LA, et al. Lipoprotein abnormalities in primary biliary cirrhosis. Gastroenterology. 1985;89:1266-1278.
3. Chait A, Brunzell JD. Acquired hyperlipidemia (secondary dyslipoproteinemias). Endocrinol Metab Clin North Am. 1990;19:259-278.
4. Crippin JS, Lindor KD, Jorgensen R, et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology. 1992;15:858-862.
5. Propst A, Propst T, Lechleitner M. Hypercholesterolaemia in primary biliary cirrhosis is no risk factor for atherosclerosis. Dig Dis Sci. 1993;38:379-383.
6. Longo M, Crosignani A, Battezzati PM, et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut. 2002;51:265-269.
7. O'Kane MJ, Lynch PL, Callender ME, et al. Abnormalities of serum apo A1 containing lipoprotein particles in patients with primary biliary cirrhosis. Atherosclerosis. 1997;131:203-210.
8. Puchois P, Kandoussi A, Fievet P, et al. Apolipoprotein A1 containing lipoproteins in coronary artery disease. Atherosclerosis. 1987;68:35-40.
9. Bloks VW, Plosch T, von Goor H, et al. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase mice. J Lipid Res. 2001;42:41-50.
10. Del Puppo MM, Galli-Kienle A, Crosignani M, et al. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. J Lipid Res. 2001;42:437-441.
11. Kurihara T, Akimoto M, Abe K, et al. Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia. Clin Ther. 1993; 15:890-898.
12. Russo MW, Jacobson IM. How to use statins in patients with chronic liver disease. Cleveland Clin J Med. 2004;71:58-62.
13. Tolman KG. The liver and lovastatin. Am J Cardiol. 2002;89:1374-1380.
14. Westphal JF, Brogard JM. Drug administration in chronic liver disease. Drug Saf. 1997;17:47-73.
15. Zachoval R, Gerbes AL, Schwandt P, et al. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial. J Hepatol. 2001;35:86-91.
16. Offstad J, Schrumpf E, Geiran O, et al. Plasma exchange and heart-liver transplantation in a patient with homozygous familial hypercholesterolemia. Clin Transpl. 2001;15:432-436.